Stay updated on Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Sign up to get notified when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.

Latest updates to the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check46 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check53 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check67 days agoChange DetectedThe website has been updated to version 2.14.1 on January 13, 2025, following the removal of version 2.14.0 on November 19, 2024.SummaryDifference1%
- Check75 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.9%
- Check104 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Testing BI 907828 in Solid Tumors With Ezabenlimab: Clinical Trial. page.